See It in Action
Five steps. One platform.
Book a 15-minute demo and see how CSI transforms your dry eye workflow.
Book a DemoOur Technology
How It Works
Point-of-care diagnostic software built on patented AI. CSI cuts gold-standard dry eye workups from 45 minutes to 15 — for optometrists and ophthalmologists, including LASIK and cataract pre-op screening — delivering evidence-based diagnosis every time.
The Process
Three Steps to Better Dry Eye Care
From patient intake to treatment plan, CSI handles the complexity so you can focus on care.
1
Data Collection
Patients complete their intake via their own device. CSI offers 4 assessment types before the exam even begins: Pre-Operative Screening for LASIK and cataract surgery, ASCRS Pre-Op, Accelerated Dry Eye Assessment, and Gold Standard.
2
AI Analysis
Patented algorithms analyse every data point through a Dews III 9-cell diagnostic grid, flag medication risks, and detect Mimickers — conditions that masquerade as dry eye disease.
3
Treatment Planning
CSI generates recommendations across 4 treatment categories: OTC, Rx, Exercises, and Procedures. Export in PDF formats, email, Patient App or Copy to EMR for seamless documentation.
Step 1
Comprehensive Patient Assessment
As point-of-care diagnostic software, CSI captures a complete picture before the patient sits in the chair. Validated questionnaires, medication history, lifestyle factors, and symptom profiles are collected digitally — giving optometrists and ophthalmologists the data they need without adding to chair time.
Send Questionnaires
| Patient | Status | |
|---|---|---|
| Jane Smith | [email protected] | Sent |
| Robert Chen | [email protected] | Completed |
| Maria Lopez | [email protected] | Pending |
Interpretation
AI
Moderate
Evaporative Dry Eye consistent with MGD. TBUT reduced bilaterally.
Low Risk
Aqueous production within normal limits. Schirmer I: 14mm OD / 16mm OS.
Dry Eye Mimickers / Co-Conditions
| Mild | Moderate | Severe | EDE | |
|---|---|---|---|---|
| ADO | ✓ | |||
| MGD | ✓ |
Medication Flags
Accutane
Antihistamines
Beta-Blockers
Step 2
Machine Learning Pattern Recognition
CSI's patented algorithms cross-reference symptom profiles, medication interactions, and clinical signs to identify patterns that are easy to miss. The 9-cell diagnostic grid maps severity across multiple axes, while Mimicker detection alerts clinicians to conditions that can masquerade as dry eye.
Step 3
Evidence-Based Recommendations
Based on the AI analysis, CSI generates structured treatment recommendations across OTC products, prescriptions, exercises, and in-office procedures. Reports are available in PDF formats, email, Patient App or can be Copied to EMR for seamless documentation.
Treatment Recommendations
OTC Products
Rx Prescriptions
Export as PDF
Under the Hood
Technical Features
Proprietary Algorithms
Patented machine-learning models trained on 40,000+ real-world dry eye assessments.
Cloud-Based SaaS
Access from any device, anywhere. No installations, no hardware. Just log in and go.
45 → 15 Minutes
Reduce comprehensive diagnostic time by 67% without sacrificing clinical rigour.
Unbiased Analysis
No product affiliations or vendor ties. Recommendations are based purely on clinical evidence — trusted by optometrists and ophthalmologists alike.
4 PDF Formats
Structured reporting for clinicians, patients, referrals, and insurance — plus Copy to EMR.
Multi-User Access
Multiple practitioners and staff per clinic, with role-based permissions and shared patient records.